Abstract
The use of hormone replacement therapy (HRT) for the relief of menopausal symptoms and the prevention of osteoporotic fractures has been advocated for some time. More recently, it has been suggested that HRT may lead to a reduction in heart disease and stroke. These benefits have to be weighed against the possibility of an increased risk of endometrial cancer and breast cancer. For individual women and their doctors, a careful assessment of the evidence on the balance of risks and benefits is of great importance. For a health service with limited resources, the health benefits for individuals must be weighed against the resource costs and compared with the benefits which might be gained from spending the money on other health care programmes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weinstein MC. Estrogen use in postmenopausal women — costs, risks and benefits. N Engl J Med 1980; 303:308–16.
Weinstein MC, Schiff I. Cost-effectiveness of hormone replacement therapy in the menopause. Obstet Gynecol Surv 1983; 38:445–55.
Office of Population Censuses and Surveys. 1986 Mortality statistics: cause. London: HMSO, 1988.
Department of Health and Social Security and Welsh Office. Health Service Costing Returns: year ended 31st March 1987. London: DHSS, 1988.
Department of Health and Social Security and Office of Population Censuses and Surveys. 1985 Hospital Inpatient Enquiry. London: HMSO, 1987.
Marinker M. The referral system. J R Coll Gen Pract 1988; 38:487–90.
Hunt K, Vessey M. Long term effects of postmenopausal hormone therapy. Br J Hosp Med 1987; 38:450–60.
Persson I, Adami H-O, Bergkvist L, Lindgren A, Pettersson B, Hoover R, Schairer C. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. Br Med J 1989; 298:147–51.
Henderson BE, Pike MC, Ross RK, Mack TM, Lobo RA. Re-evaluating the role of progestogen therapy after the menopause. Fertil Steril 1988; 49 (suppl.):9S–15S.
Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal oestrogen and breast cancer risk: an expanded case-control study. Br J Cancer 1986; 54:825–32.
Gambrell RD Jr. Proposal to decrease the risk and improve the prognosis of breast cancer. Am J Obstet Gynecol 1984; 150:119–32.
Key TJ, Pike MC. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24:29–43.
Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321:293–7.
Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC. Long term prevention of postmenopausal osteoporosis by oestrogen: evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1976; i:1038–41.
Horsman A, Gallagher JC, Simpson M, Nordin BEC. Prospective trial of oestrogen and calcium in post-menopausal women. Br Med J 1977; ii:789–92.
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR. Decreased risk of fractures of hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 1980; 303:1195–8.
Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM. A case-control study of menopausal estrogen therapy and hip fractures. Ann Intern Med 1981; 95:28–31.
Christiansen C, Christensen MS, Transbol TB. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet 1981; i:459–61.
Bush TL, Cowan LD, Barret-Connor E. Estrogen use and all cause mortality: preliminary results from the Lipid Research Clinics Program follow-up study. JAMA 1983; 249:903–6.
Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985; 313:1044–9.
Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol 1986; 154:1181–6.
Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 1988; 297:519–22.
Coulter A, McPherson K, Vessey M. Do British women undergo too many or too few hysterectomies? Soc Sci Med 1988; 27:987–94.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag London Limited
About this paper
Cite this paper
Roche, M., Vessey, M. (1990). Hormone Replacement Therapy in the Menopause: Risks, Benefits and Costs. In: Drife, J.O., Studd, J.W.W. (eds) HRT and Osteoporosis. Springer, London. https://doi.org/10.1007/978-1-4471-1799-5_26
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1799-5_26
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1801-5
Online ISBN: 978-1-4471-1799-5
eBook Packages: Springer Book Archive